ClinicalTrialsFinder

Recurrent Non-Muscle Invasive Bladder Carcinoma Clinical Trials in Columbus, Ohio

1 recruitingColumbus, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 3

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Stage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8Recurrent Non-Muscle Invasive Bladder Carcinoma
Alliance for Clinical Trials in Oncology330 enrolled56 locationsNCT07000084